{"id":500,"date":"2021-06-03T20:05:00","date_gmt":"2021-06-03T11:05:00","guid":{"rendered":"https:\/\/idsc-gunma.jp\/congress\/jstm\/?p=500"},"modified":"2022-05-26T20:08:03","modified_gmt":"2022-05-26T11:08:03","slug":"%e8%86%80%e8%83%b1%e3%81%8c%e3%82%93%e3%82%92%e5%af%be%e8%b1%a1%e3%81%a8%e3%81%97%e3%81%9f%e8%86%80%e8%83%b1%e5%86%85%e6%bd%85%e6%b5%81%e3%82%b7%e3%82%b9%e3%83%86%e3%83%a0%e3%81%ab%e3%82%88%e3%82%8bhi","status":"publish","type":"post","link":"https:\/\/idsc-gunma.jp\/congress\/jstm\/%e8%86%80%e8%83%b1%e3%81%8c%e3%82%93%e3%82%92%e5%af%be%e8%b1%a1%e3%81%a8%e3%81%97%e3%81%9f%e8%86%80%e8%83%b1%e5%86%85%e6%bd%85%e6%b5%81%e3%82%b7%e3%82%b9%e3%83%86%e3%83%a0%e3%81%ab%e3%82%88%e3%82%8bhi\/","title":{"rendered":"\u8180\u80f1\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u8180\u80f1\u5185\u6f45\u6d41\u30b7\u30b9\u30c6\u30e0\u306b\u3088\u308bHIVEC\u6cbb\u7642"},"content":{"rendered":"\n

\u4e00\u793e\uff09\u65e5\u672c\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u5b66\u4f1a\u30cb\u30e5\u30fc\u30b9No.142\u3010\u5b66\u8853\u5831\u544a63\u3011<\/p>\n\n\n\n

\u6700\u8fd1\u306e\u8a71\u984c63<\/p>\n\n\n\n

\u8180\u80f1\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u8180\u80f1\u5185\u6f45\u6d41\u30b7\u30b9\u30c6\u30e0\u306b\u3088\u308bHIVEC\u6cbb\u7642<\/p>\n\n\n\n

\u6cb3\u5408\u61b2\u5eb7\uff08\u540d\u53e4\u5c4b\u5e02\u7acb\u5927\u5b66\uff09\uff0c\u8fd1\u85e4\u3000\u9686\uff08\u5bcc\u5c71\u5927\u5b66\uff09<\/p>\n\n\n\n

\u3000\u672c\u90a6\u3067\u306f\u8180\u80f1\u304c\u3093*\u306b\u5bfe\u3059\u308b\u6e29\u71b1\u6cbb\u7642\u306f\u4e00\u822c\u7684\u3067\u306f\u306a\u3044\u304c\uff0c\u4e16\u754c\u7684\u306b\u306f\u9ad8\u6e29\u8180\u80f1\u5185\u5316\u5b66\u7642\u6cd5\uff0cHIVEC\uff08hyperthermic intravesical chemotherapy\uff09\u306b\u95a2\u3059\u308b\u57fa\u790e\u30fb\u81e8\u5e8a\u7814\u7a76\u304c\u9032\u3093\u3067\u3044\u308b\uff0e\u975e\u7b4b\u5c64\u6d78\u6f64\u6027\u8180\u80f1\u304c\u3093(non-muscle invasive bladder cancer: NMIBC)\u306b\u5bfe\u3057\u3066\u306f\u7570\u306a\u308b\u52a0\u6e29\u6cd5\u3092\u7528\u3044\u305f\u8180\u80f1\u304c\u3093\u6e29\u71b1\u7642\u6cd5\u30b7\u30b9\u30c6\u30e0\u304c\u958b\u767a\u3055\u308c\u3066\u304a\u308a\uff0c\u6700\u8fd1\uff0c\u6e29\u71b1\u3068\u5316\u5b66\u7642\u6cd5\u4f75\u7528\u306b\u3088\u308b\u5b9f\u9a13\u6cbb\u7642\u7d50\u679c\u304a\u3088\u3073\u30d2\u30c8\u306e\u81e8\u5e8a\u6210\u7e3e\u304c\u5831\u544a\u3055\u308c\u305f\u306e\u3067\u7d39\u4ecb\u3059\u308b1, 2)<\/sup>\uff0e \u8180\u80f1\u304c\u3093HIVEC\u3068\u3057\u3066\u306f, MML-Medical\u304c\u958b\u767a\u3057\u305f915 MHz\u306e\u96fb\u78c1\u6ce2\u3092\u4f7f\u3046\u30a2\u30f3\u30c6\u30ca\u3092\u8154\u5185\u306b\u8a2d\u7f6e\u3057\u3066\u6e29\u71b1\u6cbb\u7642\u3092\u884c\u3046Synergo*\u30b7\u30b9\u30c6\u30e0\u3068\uff0cACTA Medical corporation\u304c\u958b\u767a\u3057\u305f\u6e29\u6c34\u704c\u6d41\u578bCOMBAT BRS* V5\u30b7\u30b9\u30c6\u30e0\u304c\u3042\u308a\uff0c\u3053\u3053\u3067\u7d39\u4ecb\u3059\u308b\u5831\u544a\u306f\u5f8c\u8005\u3092\u5229\u7528\u3057\u3066\u3044\u308b\uff0e<\/p>\n\n\n\n

\u300043\u2103\u306e\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u306f\u81ea\u7136\u514d\u75ab\u3092\u6d3b\u6027\u5316\u3057\u3066\uff0c\u8180\u80f1\u304c\u3093\u306e\u5316\u5b66\u7642\u6cd5\u306e\u611f\u53d7\u6027\u3092\u9ad8\u3081\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u308b\uff0e\u672c\u7814\u7a76\u3067\u306fCOMBAT BRS V5\u30b7\u30b9\u30c6\u30e0\u3092\u7528\u3044\u305f\u969b\u306e\u8180\u80f1\u5185\u30de\u30a4\u30c8\u30de\u30a4\u30b7\u30f3\uff08MMC\uff09\u306e\u85ac\u7269\u52d5\u614b\u3068\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u306e\u5b89\u5168\u6027\u304a\u3088\u3073\u7d44\u7e54\u6d78\u900f\u6027\u306b\u3064\u3044\u3066\uff0c\u30d6\u30bf\u306e\u8180\u80f1\u30e2\u30c7\u30eb\u3092\u4f7f\u7528\u3057\u3066\u8a55\u4fa1\u3057\u305f1)<\/sup>. \u96cc\u30d6\u30bf\uff0860 kg\uff0940 \u5339\u3092\u4f7f\u7528\u3057, MMC \u7528\u91cf\u306f 40\uff0c80\uff0c\u304a\u3088\u3073 120 mg\u3068\u3057\u3066\uff0cCOMBAT BRS\u3092\u7528\u3044\u3066\u6e29\u5ea643\u2103\u3067\u704c\u6d41\u3057\u305f\uff0e\u52a0\u6e29\u6642\u9593\u306f30\u301c180 \u5206\u9593\u3067\u3042\u3063\u305f\uff0e\u7d44\u7e54\uff0c\u8840\u6db2\uff0c\u5c3f\u306e\u8a66\u6599\u3092\u63a1\u53d6\u3057\uff0c\u6025\u901f\u51cd\u7d50\u5f8c\uff0c\u4fdd\u5b58\u3057\u305f\uff0e\u7d44\u7e54\u4e2d\u306eMMC\u6fc3\u5ea6\u306f\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u30fc\u30bf\u30f3\u30c7\u30e0\u8cea\u91cf\u5206\u6790\u88c5\u7f6e\u3067\u6e2c\u5b9a\u3055\u308c\u305f\uff0eCOMBAT BRS\u30b7\u30b9\u30c6\u30e0\u3067\u306f, 12\u5206\u9593\u3067\u76ee\u7684\u6e29\u5ea6(42\u301c44\u2103)\u306b\u9054\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u3067\uff0c\u76ee\u7684\u6e29\u5ea6\u3067\u5fc5\u8981\u6642\u9593\u306e\u7dad\u6301\u304c\u53ef\u80fd\u3067\u3042\u3063\u305f\uff0e\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u3068MMC \u7528\u91cf\u304c\u8180\u80f1\u7d44\u7e54\u3078\u306e\u85ac\u5264\u6d78\u900f\u6027\u306b\u5f71\u97ff\u3057\u305f\u304c\uff0c\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u4f75\u7528\u7fa4\u3067\u306f80 mg\u4f7f\u7528\u6642\u3067\u8180\u80f1\u7d44\u7e54\u3078\u306eMMC\u6d78\u900f\u6027\u306f\u6700\u9ad8\u3068\u306a\u3063\u305f\uff0e\u307e\u305f\uff0c43\u2103\uff0c120 mg \u4f7f\u7528\u6642\u3067\u3082\u809d\u81d3, \u5fc3\u81d3, \u814e\u81d3, \u813e\u81d3\uff0c\u80ba, \u30ea\u30f3\u30d1\u7bc0\u3067\u306eMMC\u6fc3\u5ea6\u306f\u6b63\u5e38\u4f53\u6e29\u6642\u3068\u6bd4\u3079\u3066\u6709\u610f\u306a\u4e0a\u6607\u306f\u306a\u304b\u3063\u305f\uff0e\u672c\u30b7\u30b9\u30c6\u30e0\u306b\u3088\u308a\u5b89\u5168\u306b\u8180\u80f1\u304c\u3093\u6e29\u71b1\u6cbb\u7642\u304c\u65bd\u884c\u3067\u304d\uff0c43\u2103\u52a0\u6e29\u304c\u53ef\u80fd\u3067\u3042\u3063\u305f\uff0e\u307e\u305f\uff0cMMC\u3068\u306e\u4f75\u7528\u306f\u8180\u80f1\u7d44\u7e54\u3078\u306e\u85ac\u5264\u6d78\u900f\u6027\u3092\u4e0a\u3052\u308b\u304c\uff0c\u4ed6\u81d3\u5668\u3078\u306e\u5f71\u97ff\u306f\u306a\u3044\u3068\u601d\u308f\u308c\u308b\uff0e<\/p>\n\n\n\n

\u3000BCG*<\/strong>\u8180\u80f1\u5185\u6ce8\u5165\u7642\u6cd5\u306fNMIBC\u306e\u6cbb\u7642\u3068\u3057\u3066\u4e16\u754c\u7684\u6a19\u6e96\u6cbb\u7642\u3067\u3042\u308b\u304c\uff0c10\u5e74\u7a0b\u524d\u304b\u3089\u4f9b\u7d66\u696d\u8005\u304c\u6e1b\u5c11\u3057, \u4e16\u754c\u7684\u306b\u3082BCG\u4e0d\u8db3\u306b\u306a\u308a\u3064\u3064\u3042\u308b\uff0e\u3053\u306e\u305f\u3081BCG\u8180\u80f1\u5185\u6ce8\u5165\u7642\u6cd5\u306b\u66ff\u308f\u308bNMIBC\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u304c\u5168\u4e16\u754c\u7684\u306b\u55ab\u7dca\u306e\u8ab2\u984c\u3067\u3042\u308b\u3053\u3068\u3092\u8003\u616e\u3057\u3066\uff0cCOMBAT\u30b7\u30b9\u30c6\u30e0\u3068\u9ad8\u7528\u91cfMMC\u3092\u7528\u3044\u305f\u81e8\u5e8a\u7814\u7a76\u304c\u884c\u308f\u308c\u305f2\uff09<\/sup>\uff0e\u4e2d\u30ea\u30b9\u30af\uff084\u540d\uff09\u304a\u3088\u3073\u9ad8\u30ea\u30b9\u30af\uff0810\u540d\uff09\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b120 mg MMC\u3092\u7528\u3044\u3066\uff0c43\u2103 HIVEC\u304c\u65bd\u884c\u3055\u308c\u305f\uff0e\u77ed\u3044\u89b3\u5bdf\u671f\u9593\u3067\u3042\u308b\u304c\uff0c1\u5e74\u9593\u306e\u89b3\u5bdf\u671f\u9593\u3067\uff0c\u7b4b\u5c64\u6d78\u6f64\u764c\u3078\u306e\u9032\u5c55\u306f\u8a8d\u3081\u306a\u304b\u3063\u305f\u304c\uff0c2\u4f8b\u306bNMIMC\u306e\u518d\u767a\u3092\u8a8d\u3081\u305f(15%).\uff17\u4f8b\u3067\u30b0\u30ec\u30fc\u30c91\u304a\u3088\u30732\u306e\u6709\u5bb3\u4e8b\u8c61\u304c\u3042\u308a\uff0cMMC\u30a2\u30ec\u30eb\u30ae\u30fc\u3068\u8180\u80f1\u306e\u75d9\u6523\u3067\u3042\u3063\u305f\uff0e\u518d\u767a\u3057\u305f2\u4f8b\u306f\u6709\u5bb3\u4e8b\u8c61\u306e\u305f\u3081HIVEC\u304c2\u56de\u3057\u304b\u65bd\u884c\u3067\u304d\u306a\u3044\u75c7\u4f8b\u3067\u3042\u3063\u305f\uff0e\u4eca\u5f8c\uff0c\u75c7\u4f8b\u6570\u3092\u5897\u3084\u3057\u305f\u9577\u671f\u89b3\u5bdf\u7814\u7a76\u304c\u5fc5\u8981\u3067\u3042\u308b\u304c\u672c\u6cbb\u7642\u306f\u5b89\u5168\u306b\u65bd\u884c\u3067\u304d\u308b\u3053\u3068\u304c\u5224\u660e\u3057\u305f\uff0e\u6e29\u5ea6\u7ba1\u7406\u3082\u3057\u3084\u3059\u3044\u8180\u80f1\u306f\u6e29\u71b1\u7642\u6cd5\u306e\u5bfe\u8c61\u3068\u3057\u3066\u9069\u3057\u3066\u304a\u308a\uff0c\u672c\u90a6\u3067\u3082HIVEC\u7642\u6cd5\u304c\u9032\u3080\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u308b\uff0e<\/p>\n\n\n\n

\u53c2\u8003\u6587\u732e<\/p>\n\n\n\n

  1. Tan WP et al.<\/em> Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study. Int J Hyperthermia 37: 854-60, 2020.<\/li>
  2. Grimberg DC et al<\/em>. Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladdercancer during BCG shortage. Urol Oncol. S1078-1439(20)30654-2, 2021.<\/li><\/ol>\n\n\n\n

    \u7528\u8a9e\u8aac\u660e<\/p>\n\n\n\n

    *\u8180\u80f1\u304c\u3093\uff1a\u7b4b\u5c64\u975e\u6d78\u6f64\u6027\u306e\u8180\u80f1\u304c\u3093\uff08NMIBC\uff09\u306f\uff0c\u521d\u767a\u8180\u80f1\u304c\u3093\u5168\u4f53\u306e70\uff05\u304b\u308980\uff05\u3092\u5360\u3081\u308b\uff0e\u7d4c\u5c3f\u9053\u7684\u8180\u80f1\u816b\u760d\u5207\u9664\u8853\uff08TURBT\uff09\u3067\u5207\u9664\u3057\u3066\u3082\u518d\u767a\u3092\u7e70\u308a\u8fd4\u3057\u3084\u3059\u304f\uff0c\u7b4b\u5c64\u6d78\u6f64\u6027\u304c\u3093\u3078\u306e\u79fb\u884c\u53ef\u80fd\u6027\u3082\u3042\u308a\uff0cTURBT\u304b\u3089\u5224\u65ad\u3055\u308c\u308b\u30ea\u30b9\u30af\u5206\u985e\u306b\u5f93\u3063\u3066\u6cbb\u7642\u65b9\u91dd\u304c\u6c7a\u5b9a\u3055\u308c\u308b\uff0e\u91cd\u8981\u306a\u76ee\u7684\u306f\uff0c\u5207\u9664\u5f8c\u306e\u6297\u304c\u3093\u5264\u3084\u5f31\u6bd2\u5316\u30a6\u30b7\u7d50\u6838\u83cc\uff08BCG\uff09\u306e\u5c0e\u5165\u30fb\u7dad\u6301\u7642\u6cd5\u3092\u99c6\u4f7f\u3057\u305f\u518d\u767a\u4e88\u9632\u3067\u3042\u308b\uff0e<\/p>\n\n\n\n

    \uff081\uff09\u4f4e\u30ea\u30b9\u30af\u7fa4\u3067\u306f\uff0cTURBT\u76f4\u5f8c\uff0824\u6642\u9593\u4ee5\u5185\uff09\u306e\u6297\u304c\u3093\u5264\u6ce8\u5165\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u308b\uff0e<\/p>\n\n\n\n

    \uff082\uff09\u4e2d\u30ea\u30b9\u30af\u7fa4\u3067\u306f\uff0c\u6297\u304c\u3093\u5264\uff0c\u307e\u305f\u306fBCG\u306e\u5c0e\u5165\u7642\u6cd5\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u308b. \u7d4c\u904e\u89b3\u5bdf\u3067\u518d\u767a\u3084\u9032\u5c55\u304c\u78ba\u8a8d\u3055\u308c\u305f\u5834\u5408\u306f\u6297\u304c\u3093\u5264\u3082\u3057\u304f\u306fBCG\u306e\u7dad\u6301\u7642\u6cd5\u307e\u305f\u306f\u8180\u80f1\u5168\u6458\u9664\u8853\u306e\u9078\u629e\u304c\u5224\u65ad\u3055\u308c\u308b\uff0e<\/p>\n\n\n\n

    \uff083\uff09\u9ad8\u30ea\u30b9\u30af\u7fa4\u3067\u306f2\u56de\u76ee\u306eTURBT\u3092\u5b9f\u65bd\u3057\uff0cBCG\u7dad\u6301\u7642\u6cd5\uff0c\u307e\u305f\u306f\u8180\u80f1\u5168\u6458\u9664\u8853\u304c\u9078\u629e\u3055\u308c\u308b.<\/p>\n\n\n\n

    *Synergo system:<\/strong> MML-Medical\u304c\u958b\u767a\u3057\u305fHIVEC\u7528\u6e29\u71b1\u7642\u6cd5\u88c5\u7f6e\uff0e915 MHz\u7528\u96fb\u78c1\u6ce2\u767a\u4fe1\u88c5\u7f6e\uff0c\u85ac\u5264\u6f45\u6d41\u30e6\u30cb\u30c3\u30c8\uff0c\u304a\u3088\u3073\u30de\u30a4\u30af\u30ed\u30d7\u30ed\u30bb\u30c3\u30b5\u30fc\u3067\u69cb\u6210\u3055\u308c\u308b\uff0e<\/p>\n\n\n\n

    *COMBAT BRS V5: COMB<\/strong>ined A<\/strong>ntineoplastic T<\/strong>hermotherapy B<\/strong>ladder R<\/strong>ecirculation S<\/strong>ystem\u306e\u7565\u3067\uff0cACTA Medical corporation\u306b\u3088\u308bHIVEC\u7528\u8180\u80f1\u6f45\u6d41\u6e29\u71b1\u7642\u6cd5\u88c5\u7f6e\uff0eNMIBC\u306e\u6cbb\u7642\u30b7\u30b9\u30c6\u30e0\u3067\u9769\u65b0\u7684\u306a\u518d\u5faa\u74b0\u30b7\u30b9\u30c6\u30e0\u3092\u5229\u7528\u3057\u3066\u3044\u308b.<\/p>\n\n\n\n

    *BCG \uff1a\u4ecf\u8a9e\u306e Bacille de Calmette et Gu\u00e9rin \u306e\u7565.\u30ab\u30eb\u30e1\u30c3\u30c8\u30fb\u30b2\u30e9\u30f3 \u687f\u83cc\u3068\u306f, \u30a6\u30b7\u578b\u7d50\u6838\u83cc \uff08 \u82f1\u8a9e: Mycobacterium bovis \uff09\u306e\u5b9f\u9a13\u5ba4\u57f9\u990a \u3092\u7e70\u308a\u8fd4\u3057\u3066\u4f5c\u88fd\u3055\u308c\u305f\u7d30\u83cc, \u304a\u3088\u3073, \u305d\u308c\u3092\u5229\u7528\u3057\u305f \u7d50\u6838\u306b\u5bfe\u3059\u308b \u751f\u30ef\u30af\u30c1\u30f3 \uff08 BCG\u30ef\u30af\u30c1\u30f3 \uff09\u306e\u3053\u3068. \u672c\u6765\u306f\u524d\u8005\u306b\u3042\u305f\u308b\u7d30\u83cc\u305d\u306e\u3082\u306e\u3092\u6307\u3059\u8a9e\u3067\u3042\u3063\u305f\u304c,\u533b\u5b66\u5206\u91ce\u3067\u306f\u5f8c\u8005\u3092\u5358\u306b\u300cBCG\u300d\u3068\u547c\u3076\u5834\u5408\u304c\u591a\u3044\uff0e<\/p>\n","protected":false},"excerpt":{"rendered":"

    \u4e00\u793e\uff09\u65e5\u672c\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u5b66\u4f1a\u30cb\u30e5\u30fc\u30b9No.142\u3010\u5b66\u8853\u5831\u544a63\u3011 \u6700\u8fd1\u306e\u8a71\u984c63 \u8180\u80f1\u304c\u3093\u3092\u5bfe\u8c61\u3068\u3057\u305f\u8180\u80f1\u5185\u6f45\u6d41\u30b7\u30b9\u30c6\u30e0\u306b\u3088\u308bHIVEC\u6cbb\u7642 \u6cb3\u5408\u61b2\u5eb7\uff08\u540d\u53e4\u5c4b\u5e02\u7acb\u5927\u5b66\uff09\uff0c\u8fd1\u85e4\u3000\u9686\uff08\u5bcc\u5c71\u5927\u5b66\uff09 \u3000\u672c\u90a6\u3067\u306f\u8180\u80f1\u304c\u3093*\u306b\u5bfe\u3059 […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"vkexunit_cta_each_option":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-500","post","type-post","status-publish","format-standard","hentry","category-report"],"_links":{"self":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/comments?post=500"}],"version-history":[{"count":1,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/500\/revisions"}],"predecessor-version":[{"id":501,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/500\/revisions\/501"}],"wp:attachment":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/media?parent=500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/categories?post=500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/tags?post=500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}